Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs Nebius Group NV (NBIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elanco Animal Health Incorporated Common Stock vs Nebius Group NV — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.92 (market cap $11.26B), while Nebius Group NV trades at $221.49 (market cap $59.73B). The key difference: Nebius Group NV is far larger — about 5.3× Elanco Animal Health Incorporated Common Stock's market cap, and Nebius Group NV is trading nearer its 52-week high, Elanco Animal Health Incorporated Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 1 Days and Nebius Group NV for 24 Days on average.
| ELAN | NBIS | |
|---|---|---|
Market Cap | $11.26B | $59.73B |
Volume | 4,570,386 | 21,563,700 |
Sector | Health | Technology |
52-Week High | $26.84 | $286.69 |
52-Week Low | $19.76 | $73.87 |
Typical Hold Time | 1 Days | 24 Days |
Enterprise Value | $14.65B | $61.86B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NBIS trades at $221.12, down 6.73% over 24 hours amid a bearish technical signal. The stock shows strong analyst support with an 81.82% buy rating and a $288.67 consensus price target, but faces high valuations with a P/E of 845.04 and negative earnings in recent quarters. Recent news highlights AI infrastructure growth potential, including a $37 billion backlog and strategic acquisitions like Inferize, though insider selling and competitive pressures pose concerns.
The outlook for NBIS hinges on executing its AI cloud expansion, with revenue projected to surge from $530 million in 2025 to $1.4 billion in 2026. Risks include elevated debt from aggressive investing, negative net income margins, and potential AI market volatility. The stock offers upside if growth targets are met but remains sensitive to sector sentiment and financing stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elanco Animal Health Incorporated Common Stock
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →
